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confirmed by classical methods with DNA of normal
controls with measured proportion of 12.5%, 25%, 30%,
50% and 75% admixture of trisomic DNA to total DNA.
DNA from amniotic cells was extracted using
QIAamp DNA Blood Mini Kit samples. D concen-
trations were measured by a spectrophotometer
Lambda Bio Plus and in all cases normalized.
The level of detection differs between particular
trisomies; in trisomy 21, this method regularly detects
trisomy whether the concentration of trisomic DNA is
30% (in some but not all cases in 25% and rarely in
12.5%). In trisomies 13 and 18, the borderline of
detection is higher and in both stays at the level of 50%.
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A chromosomal inversion involves chromosome
breaks at two different sites, followed by a 180°
rotation and reunion of the intrachromosomal seg-
ment. Inversions have an incidence of 0.13/10,00
liveborns. Phenotypic manifestations occur when a
critical gene is disrupted.
The short arm of chromosome 17 is a recognized
region of genomic instability. Genomic rearrange-
ments at 17p13.3 include interstitial deletions and
duplications. Array comparative genomic hybridiza-
tion (aCGH) has allowed the identification of a
growing number of new microdeletion and micro-
duplication syndromes that cause mental retardation.
Submicroscopic duplications are now being reported
for almost all microdeletions syndromes and have a
distinct behavioral and phenotypic expression.
A prenatal diagnosis performed at the 17th week
gestation, because of advanced maternal age, revealed
by GTG banding the presence of a de novo abnormal
chromosome 17. Fluorescence in situ hybridization
techniques were performed using WCP, p53, subtelo-
meric 17p, Miller-Dieker, Smith-Magenis and Her2/
neu probes. These hybridizations showed that only
the chromosome 17 was involved and that there is the
presence of a complex rearrangement involving
several breakpoints.
To determine whether there was any microdeletion
or microduplication, aCGH analysis was performed
with a Microarray Agilent 180k, showing that there
were two microduplications: one of 558 kb on
17p13.2–p13.3 and another of 76 kb on 17q12, in
two of the breakpoints established, with no disequi-
librium of the subtelomeric region. Anatomophato-
logical studies revealed no alterations in the fetus.
Our report describes an abnormal chromosome 17
with at least three inversions, two paracentric (in the
short arm) and one pericentric. Genomic duplications
in the terminal end of the short arm of chromosome
17 are of particular interest because many of them have
been shown to be related to neurologic disorders.
This is the first report of a prenatal diagnosis with
an intrachromosomic rearrangement in chromosome
17, involving at least three breakpoints, with two
microduplications detected by aCGH.
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The majority of 11q deletion cases described may be
included in the “distal 11q deletion syndrome”, or
Jacobsen syndrome. This is a rare but clinically
recognizable condition with an incidence of 1/
100,000 births. The most common clinical features
are psychomotor delay, characteristic facial dysmor-
phism and malformations of the heart, kidney,
genitalia, central nervous system and skeleton.
Patients usually have visible deletions of chromosom-
al bands 11q23, 11q24, and/or 11q25. Approximately
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85% of the cases are de novo deletions, and only a
few prenatal cases have been reported.
We report the clinical case of a 30-year-old
pregnant woman who was referred to our laboratory
with a positive first trimester prenatal screening for
Down syndrome.
The cytogenetic analysis revealed a terminal
deletion on the distal 11q chromosome. Fluorescence
in situ hybridization using a whole-chromosome
painting probe and subtelomeric probes confirmed
the terminal deletion and excluded other material
involvement. Parental karyotypes were normal. Sec-
ond trimester ultrasound revealed clinodactyly and a
cardiac defect described as a subvalvular and intra-
ventricular communication. The couple opted for
medical termination of pregnancy.
The postmortem examination of the 22-week fetus
showed facial dysmorphism, cardiac defects and
uterus bicornis.
There are few reports of prenatally diagnosed 11q−,
and there seems to be a phenotypic variability. Some
cases had a positive prenatal screening for Down
syndrome and/or abnormal prenatal ultrasound with
olygohydramnios, nuchal thickening, heart malforma-
tions and kidney anomalies. Other reports mention no
structural fetal abnormalities.
The present case, similar to others, had a positive
first trimester screening. The fetus presented abnor-
mal fingers, cardiac defects and malformations of
genital tract, identified at the second trimester, which
is consistent with the del11q− phenotype. This case
reinforces the phenotypic variability associated with
partial monosomy of distal 11q in the fetus and
the difficulty of establishing genotype–phenotype
correlations.
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Carriers of de novo balanced reciprocal translocations or
inversions are believed to have 6–9% risk of congenital
malformations and/or developmental delay. However,
systematic data regarding late-onset disorders are lack-
ing. A cohort (N=41) of unselected carriers of de novo
balanced reciprocal translocations or inversions
detected prenatally in the period 1970–2008 was
identified in the Danish Cytogenetic Central Register.
Using information obtained in national medical regis-
tries, we compared morbidity in the cohort to that of a
5:1 matched control group (N=205). Carriers were
offered clinical reexamination, analysis with Affyme-
trix SNP 6.0 Array, and breakpoint mapping by next-
generation sequencing (NGS) mate-pair analysis.
We observed no serious congenital malformations in
the unselected cohort. However, the risk of neuro-
developmental and/or psychiatric disorders, including
mental retardation, learning disabilities, severe attention
and/or behavioral disorders, autism spectrum disorders,
and severe mood disorders, was significantly elevated
(19.5% vs. 8.3% among the controls, p=0.04). Analysis
for copy number variants >100 kb did not provide
prognostic information about late-onset disorders. By
mate-pair analysis of the first nine affected and ten
unaffected carriers, we could detect the breakpoints
involved in ~90% of the cases. Although genes were
truncated in both groups, truncated genes known to be
associated with related phenotypes (e.g. NPAS3) were
Chromosome Res (2011) 19 (Suppl 1):S37–S231 S223
